Teza Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Teza Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $180,645 - $264,406	8,521 New	8,521 $260,000
Q2 2023 Feb 22, 2024	SELL	$25.16 - $41.38 $64,988 - $106,884	-2,583 Reduced 30.31%	5,938 $211,000
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $224,628 - $369,440	8,928 New	8,928 $318,000
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $153,664 - $222,593	5,488 New	5,488 $222,000
Q3 2021 Nov 10, 2021	SELL	$58.38 - $84.96 $796,011 - $1.16 Million	-13,635 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$62.15 - $90.32 $847,415 - $1.23 Million	13,635 New	13,635 $1.13 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.